Aerovance, Inc.

In Vitro Diagnostics Boston Heart Lab Corp. Boston Heart Lab brings in $10mm through its Series C round Sep. — Boston Heart Lab Corp. (heart disease diagnostics) has raised $10mm through the closi

Activity in the drug delivery sector has been geared towards alliances in 2009, says Phil Greenfield. The drug delivery sector was worth an estimated $50 billion in 2008 and is now a major sector of

Investments in private pharmaceutical and biotech companies slumped by 24% in April, with the market being once again dominated by US companies, a Scrip analysis has found. A total of 12 companies r

Aerovance has secured $38 million to support a Phase IIb clinical trial and future studies of its inhaled Aerovant in patients with uncontrolled asthma. The firm has already closed $20 million of the